Oncology experts drive the GIRO initiative to advocate for equitable access to radiotherapy as an essential part of multidisciplinary cancer care
Mei Ling Yap
Mei Ling Yap is a staff specialist radiation oncologist and director of training at Liverpool and Macarthur Cancer Therapy Centres, Sydney, Australia. She holds a conjoint senior lecturer appointment with the University of Western Sydney and University of New South Wales and an adjunct senior lecturer appointment with the University of Sydney.
From 2007-2012, Mei Ling undertook her radiation oncology speciality training in Australia, Singapore and Canada. Mei Ling is currently undertaking a PhD with the University of NSW, Cancer Council NSW and Collaboration for Cancer Outcomes Research and Evaluation (CCORE), exploring the socio-demographic factors which influence radiotherapy utilization in Australia.
Main Interests and Global Collaborations
Mei Ling was a member of the Global Task Force in Radiotherapy on Cancer Control (GTFRCC) and co-author of the Lancet Oncology Commission. Mei Ling is co-chair of the Asia Pacific Radiation Oncology Special Interest Group (APROSIG-RANZCR), which supports LMIC radiotherapy departments in the Asia-Pacific through a bilateral exchange, training and education. She also co-runs GlobalRT, an online platform advocating for equitable access to radiotherapy globally. Mei Ling was selected as a UICC ‘Young Cancer Leader’ in 2015.
The marked inequity in access to radiotherapy in low and middle-income countries is a current global health crisis. Every cancer patient should have access to this cost-effective, beneficial treatment. I am excited to be able to collaborate with international colleagues who are dedicated to working on this issue, through the GIRO project.